Katie L. McCarty

APOE genotype-dependent pharmacogenetic responses to rapamycin for preventing Alzheimer's disease

F. Hyder, B. G. Sanganahalli, E. Head, 2020, Neurobiology of Disease.

Is Apolipoprotein E4 an Important Risk Factor for Dementia in Persons with Down Syndrome?

E. Head, T. Rohn, Katie L. McCarty, 2014, Journal of Parkinson's disease and Alzheimer's disease.

Microbleeds and Cerebral Amyloid Angiopathy in the Brains of People with Down Syndrome with Alzheimer's Disease.

F. Schmitt, E. Abner, E. Head, 2019, Journal of Alzheimer's disease : JAD.

Proteolytic Cleavage of Apolipoprotein E in the Down Syndrome Brain

E. Head, T. Rohn, Katie L. McCarty, 2016, Aging and disease.

A combination cocktail improves spatial attention in a canine model of human aging and Alzheimer's disease.

M. Murphy, A. Dowling, E. Head, 2012, Journal of Alzheimer's disease : JAD.

Distribution of microglial phenotypes as a function of age and Alzheimer's disease neuropathology in the brains of people with Down syndrome

F. Schmitt, E. Head, I. Lott, 2020, Alzheimer's & dementia.

Down syndrome individuals with Alzheimer's disease have a distinct neuroinflammatory phenotype compared to sporadic Alzheimer's disease

F. Schmitt, D. Wilcock, M. Murphy, 2015, Neurobiology of Aging.

Down syndrome: age-dependence of PiB binding in postmortem frontal cortex across the lifespan

F. Schmitt, M. Murphy, H. Levine, 2017, Neurobiology of Aging.

DOWN SYNDROME: AGE-DEPENDENCE OF PIB BINDING IN POSTMORTEM FRONTAL CORTEX ACROSS THE LIFESPAN

F. Schmitt, H. Levine, E. Head, 2017, Alzheimer's & Dementia.